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It has previously been shown  (1)  that, following the  intradermal 
injection of the type-specific polysaccharides of Pneumococcus, there 
develops  in  the  skin  of  patients  convalescent from  pneumonia  an 
immediate wheal and erythema reaction to the polysaccharide homo- 
logous in type to that of the pneumococcus causing the infection.  The 
reaction is type-specific and its occurrence is always associated with the 
presence in the patient's serum of specific antibodies for the homolo- 
gous type of Pneumococcus. 
Since the purified carbohydrates are capable of eliciting this striking 
response in the skin of human individuals who, upon  recovery from 
lobar pneumonia become spontaneously immune, it  seemed desirable 
to study the cutaneous reactivity of experimental animals which had 
been artificially immunized to type-specific pneumococci.  The pur- 
pose of this paper,  therefore, is  to report  the occurrence of a  local 
cutaneous  reaction  to  the  type-specific  polysaccharides  in  rabbits 
actively or passively immunized to the pneumococcus. 
Materials  and  Methods 
1. Immunization  of Rabbits.-- 
(a) Active Immunization.--Groups  of rabbits were immunized with pneumo- 
cocci of Types I, II or III.  Other  animals were immunized with a non-type- 
specific R strain of pneumococcus.  Immunization was carried out by the method 
of Cole and Moore (2).  10 days after the final injection, blood was obtained from 
an ear vein and the serum tested for the presence of type-specific  antibodies. 
(b) Passive  Immunization.--Antipneumococcus  rabbit  serum was obtained 
from animals immunized as above.  Anfipneumococcus  horse serum for each of 
Types I, II and III was obtained from the New York State Board of Health. 
Rabbits were passively immunized by the intravenous injection of 5 to 15 cc. of 
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one or other of these sera.  The following day blood was obtained from an ear vein 
for the determination of circulating type-specific antibodies. 
2. Determination of Type-Specific Antibodies.-- 
(a)  Type-specific antibodies  were  detected  by the  precipitin  test;  0.2  co.  of 
serum diluted to 0.5 co. with physiological saline was mixed with 0.5 ec. of varying 
dilutions of the type-specific polysaccharides.  Readings were made after 2 hours 
in the water bath at 37°C. and overnight in the ice box. 
(b)  Type-specific agglutinins were determined by the usual method using dilu- 
tions of serum and suspensions of heat-killed organisms. 
3. Skin Testing Materials.--Skin tests were made with the capsular polysac- 
charides of pneumococcus derived in purified form from Pneumococcus Types I, 
II and III.  These substances  are  chemically and serologically distinct.  They 
are protein-free.  The Type II and Type II polysaccharides are also nitrogen- 
free; the Type I  material contains 5 per cent non-protein nitrogen which is part 
of the sugar molecule  (3).  The polysaccharides were dissolved in physiological 
saline in a concentration of 1:200 and 0.l co. of this solution,  containing 0.5 mg. 
of polysaccharide, was used for each injection.  The animals were closely observed 
for the  occurrence of an  immediate  or  delayed reaction.  Measurements  were 
recorded 24 hours following the injection and daily thereafter. 
In most ~nstances the specific capsular polysaccharides of Types I, II and III 
Pneumococcus were injected simultaneously into neighboring sites in the rabbit's 
skin. 
Skin Reactions  in Actively Immunized  Rabbits 
Three  series of rabbits  were  actively immunized with pneumococci 
of Types I,  II and III, respectively.  After immunization,  injections 
of the type-specific polysaccharides into the skin were made. 
Protocols  of  rabbits  representative  of  the  three  different  immune 
groups  illustrate  the  conditions  of  experiment  and  characteristic 
results. 
Rabbit 4-74 was actively immunized  to Type I  Pneumococcus by the intrave- 
nous route.  10 days after the final immunizing injection, the animal's serum con- 
tained specific  precipitins  for the Type I  polysaccharide in a  titer  of 2,560,000. 
The following day injections of 0.5 rag. of each of Types I, II and III polysaccha- 
rides  were made  into  the  shaved skin of the side.  2½  hours later  a  few faint 
purpuric spots were observed at the site of injection of the Type I material.  The 
lesion increased in size  until at  24 hours a  purpuric edematous area 2.5  cm. in 
diameter was noted.  In 48 hours the diameter had reached 3.0 cm., the edema 
was less but the purpura had darkened and infiltration had increased.  A gradual 
clearing took place over the next 4 days.  At the sites of injection of the Type II 
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Rabbit 4-41 was actively ;mmunlv,  d against Type II Pneumococcus.  10 days 
after immunization was completed the serum contained precipitins  for the Type II 
polysaccharide  in a titer of 1,280,000.  The following day, injections  of 0.5 rag. 
of each of the Type I, II and III polysaccharides  were made into the skin of the 
side.  24 hours later,  at the site of injection of the Type II polysaccharide,  a firm 
edematous lesion, bright red in color, and measuring  4.5 cm. x 2.3 cm. in cross 
diameters  was  noted.  No  purpura  was  present.  The  lesion  had  practically 
cleared in 4 days.  No reaction was elicited by the carbohydrates of Types I and 
III. 
Rabbit  14-85 was immunized  with a strain of Type nI Pneumococcus  which 
had, by repeated animal passage,  acquired  virulence  for rabbits.  On the  10th 
day after the last immunizing dose the serum contained precipitins for the Type III 
polysaccharide.  With a 1:80,000 dilution of the polysaccharide  a  + + + +  reac- 
TABLE  I 
Skin  Reactions  to  Type-Specific  Polysacchari.des in  Rabbits  Actively  Immunized 
with Pneumococci of Homologous Types 
Type of  Type-specific  precipitins present  No type-specific  precipitins present 
Pneumococcus used 
for immunization  No. of rabbits  No. giving skin  No. of rabbits  No. giving skin 
reaction  reaction 
I  11  10  4  0 
II  9  8  3  0 
III  5  3  8  0 
R  --  --  5  0 
tion was  obtained.  Higher dilutions  were  not  tested.  The following day 0.5 
rag. of each of the polysaccharides  of Types I, II and III was injected  into the 
shaved skin of the side.  After 24 hours at the site of injection  of the TypelII 
polysaccharide,  there was noted a slightly elevated,  firm, purpuric area 2.6 x 3.4 
cm. in diameter,  surrounded by a  white  zone of edema.  The lesion gradually 
subsided until the 6th day when only a faint pigmentation remained.  The reac- 
tion  was  type-specific;  no  reaction  was  produced  by  the  Types  I  and  II 
carbohydrates. 
The  foregoing protocols demonstrate  dearly the  form of reaction 
obtained and the  conditions under which it was produced.  Table I 
shows the  frequency with  which  skin  reactions were  elicited  by the 
intradermal  injection  of  the  homologous polysaccharide  in  rabbits 
actively immunized with pneumococci of Types I, II or III,  or with 
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It is seen in Table I  that of twenty-five animals  yielding serum in 
which type-specific precipitins were present, all but four gave a typical 
local inflammatory reaction to the injection of the carbohydrate of the 
homologous type.  In these four instances the titer of antibodies was 
lower than in the reactive animals.  On the other hand, those animals 
in which circulating type-specific precipitins could not be demonstrated 
failed in every instance to give a positive response.  No reaction was 
obtained in any case except to the homologous type-specific polysac- 
charide. 
In contrast to the immediate wheal and erythema reaction produced 
by the carbohydrates in patients convalescent from lobar pneumonia, 
the reaction produced in the artificially immunized rabbits is usually 
first detected after 6 to 8 hours.  The reaction makes its appearance 
as  a  faint  blush  and  gradually  increases  in  size,  producing  a  pink 
edematous area frequently surrounded by a zone of pale edema.  The 
edema tends to increase and erythema is replaced by a  purplish  dis- 
coloration.  The  lesion  reaches  its  height  in  24  to  48 hours  and  at 
that time it may be 4 to 5 cm. in diameter and  0.5 to 1.0 cm. in eleva- 
tion.  A gradual regression takes place in 4 to 7 days until little or no 
trace  of  the  reaction  remains.  With  the  doses  employed  necrosis 
of  the  skin  has  not  been  observed.  The  cutaneous  reaction  was 
produced in rabbits only by the  polysaccharide homologous in  type 
to that of the pneumococcus employed in the process of immunization. 
The  severity of reaction  appears  to  be related  to  the  titer of  type 
specific precipitins for the homologous polysaccharide  in the serum of 
the animal.  In certain instances, despite the presence of type-specific 
precipitins,  no  cutaneous response was evoked by the  carbohydrate, 
but in no case was a  reaction produced in the absence of  circulating 
type-specific  precipitins. 
Skin Reactions in Passively  Immunized Ra3bits 
Attempts  were  made  to  transfer  reactivity,  passively,  to  normal 
rabbits  by the  intravenous  injection  of serum from immune  rabbits 
known to give positive skin  tests and  the serum of which contained 
a  high  titer  of type-specific precipitins.  5  to  40  cc.  of serum  were 
injected.  In none of the recipient  animals,  however, was a  positive 
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The failure in these instances may be due to the fact that insufficient 
immune serum was injected. 
Attempts  were  next  made  to  induce  skin  reactions  to  the  type- 
specific polysaccharides  in  animals  passively immunized  with serum 
of horses  immune  to  Pneumococcus Types  I,  II  or  III.  Fourteen 
rabbits  were  injected:  five with  Type I  serum,  three  with  Type II 
serum and six with Type III serum.  10 to  15 cc. of immune serum 
were  injected  intravenously,  although  in  one  rabbit  only  5  cc.  of 
serum were used.  The following day the serum of all the passively 
immunized  rabbits  was  found  to  contain  a  high  titer  of precipitins 
for the homologous polysaccharide and in each instance a well marked 
cutaneous response to the intradermal  injection of the polysaccharide 
occurred.  The character of the reaction was identical in every respect 
with that obtained in actively immunlzed  animals.  No reactions to 
the polysaccharides of heterologous types were observed. 
Local passive transfer  of sensitivity was carried out in rabbits by 
infiltrating  each of two  areas  of skin with  1.0  cc. of immune  horse 
serum.  After 24 hours there were seen at the sites of serum infiltra- 
tion small fiat areas of erythema.  Into one of these areas 0.5 rag. of 
the  homologous polysaccharide  was injected  and  into  the  other,  as 
control, an equal amount of a heterologous polysacchafide.  24 hours 
later,  at  the site of inoculation  of the homologous polysaccharide,  a 
deep red, elevated edematous area 2 to 4 cm. in diameter was observed 
and  this  persisted  for 48  to  72  hours.  At  the control site there  re- 
mained only a pale erythema due to infiltration of the serum. 
Guinea pigs were passively immunized by intraperitoneal injections 
of  antipneumococcus  horse  or  rabbit  serum.  The  animals  which 
received  immune  horse  serum  showed  no  signs  of  local  or  general 
reaction  to  the  subsequent intradermal  injection  of the homologous 
type-specific  polysaccharide.  Similarly,  no  cutaneous  reaction  to 
the polysaccharide was observed in those guinea pigs passively immun- 
ized with rabbit serum.  In several of the latter group, however, mild 
signs  of  general  anaphylaxis  (restlessness,  coughing,  scratching  of 
nose,  etc.)  were  noted  shortly  after  the  introduction  of the  specific 
substance into  the skin.  Tillett  and Avery (4)  were able to induce 
fatal  anaphylactic  shock  with  minute  amounts  of  the  type-specific 
polysaccharide  in  guinea  pigs  passively  sensitized  with  homologous 592  CAPSULAR  POLYSACCHARIDES  OF  PNEUMOCOCCUS 
antipneumococcus rabbit  serum.  If horse serum was employed for 
sensitization  no  response  occurred.  In  the  present  instances  the 
observation  that  anaphylactic symptoms were produced in  guinea 
pigs receiving antipneumococcus rabbit serum but not in those pre- 
pared with immune horse serum, appears to be another demonstration 
of the facts reported by these workers. 
DISCUSSION 
The  results  reported  in  the  present  paper  demonstrate that  in 
rabbits actively or passively immunized to a type-specific pneumococ- 
cus the intradermal injection of specific polysaccharide  of homologous 
type elicits  a  definite form of  cutaneous reaction.  In  contrast to 
the immediate wheal and erythema reaction observed in humans con- 
valescent from  pneumonia,  the  reaction  produced in  the  immune 
rabbit is delayed and resembles in its general appearance the form of 
reaction first described by Arthus (5).  The reaction is characterized 
by slow development, edema, erythema and purpuric discoloration. 
The capacity of the individual rabbit to give a positive skin reaction 
is closely associated with the presence of demonstrable type-specific 
precipitins  in  its  serum.  In  no  instance  was  a  positive  reaction 
observed in the absence of demonstrable type-specific precipitins.  In 
the guinea pig no local skin reaction was elicited but signs of general 
anaphylaxis were observed. 
It is plain that one can correlate the reactions induced in immunized 
individuals of three species  (man,  rabbit  and  guinea  pig)  by  the 
intradermal injection of a protein-free carbohydrate of bacterial origin. 
The result is the same, apparently, whether the immunity has been 
actively or  passively  acquired.  In  all  three  species  the  form  of 
response to carbohydrate is typical of the reactions commonly con- 
sidered to  be of an anaphylactic nature when produced by protein 
materials. 
The reactions are elicited only in the presence of specific antibodies 
for the capsular polysaccharide of Pneumococcus and then only by 
the specific polysaccharide homologous in type to that of the pneumo- 
coccus inducing  the  antibody  response.  Julianelle  has  shown  (6) 
that animals which have received repeated intravenous injections of 
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of  the pneumococcus, or have  received intracutaneous injections of 
unencapsulated  or  even  of  encapsulated  organisms  develop  only 
species-specific,  antisomatic  antibodies  and  a  hypersensitiveness for 
the proteins of the pneumococcus.  Type-specific antibodies for the 
capsular polysaccharide could not be detected in the serum of animals 
so treated, nor were any skin reactions produced by the injection of 
type-specific polysaccharides.  Similarly, in the present experiments 
no reactions to the carbohydrates were obtained in animals immunized 
to  the  R  organisms nor in  fact,  in  any  animal  the  serum of which 
contained  no  type-specific  precipitins.  Furthermore,  in  man,  the 
reaction  obtained  with  nucleoprotein  does  not  take  the  form  of  a 
wheal and erythema, but is a  delayed reaction reaching its height in 
18  to  24  hours.  It  is  evident,  therefore,  that  the  species-specific 
antisomatic, or antiprotein, antibodies play no r61e in the production 
of the skin reactions to the capsular polysaccharides.  Moreover, the 
data presented stress again the sharp type specificity of all reactions 
involving the pneumococcus capsular polysaccharides. 
The purpose of this report is not to enter into a discussion of the 
relation  between hypsersensitiveness and immunity but a  few note- 
worthy  facts  may  be  mentioned.  These  are  presented  in  tabular 
form in Table II.  Hypersensitivity to the protein of the pneumococ- 
cus can be induced in rabbits by repeated injections of nucleoprotein. 
Under these conditions, antibodies for the species-specific R  Pneumo- 
coccus develop but neither active immunity nor any capacity of the 
serum to confer passive immunity upon another species can be demon- 
strated  (7, 8).  In this case, hypersensitivity to the bacterial protein 
is not associated with increased resistance to pneumococcus infection. 
If an R  form of Pneumococcus is employed for immunization, only 
species-specific (anti-R)  antibodies appear in the serum of the animal. 
Protein hypersensitivity can be demonstrated in this animal but no 
reaction  is  elicited by  any of  the  capsular  polysaccharides  (6).  In 
addition,  the  animal  can  be  shown  to  have  acquired  an  increased 
resistance to  virulent pneumococci of Types I, II and III (8).  Hence, 
this  resistance  is not type-specific.  The height of  the  immunity is 
not great and is passively transferable only with great difficulty within 
the  same  species.  The  serum  of  such  an  animal  does  not  confer 
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hypersensitiveness associated with a broad, non-type-specific increased 
active resistance. 
When  an  animal  has been  effectively immunized with  a virulent, 
encapsulated  type-specific  pneumococcus, type-specific anticapsular 
antibodies appear in the circulating blood.  The animal has developed 
not only a highly efficient type-specific active immunity but its serum 
affords passive protection to mice against many lethal doses of pneu- 
mococci of the same type.  This type-specific immunity is the form 
observed  in  convalescents  from  lobar  pneumonia.  In  association 
with immunity due to type-specific antibodies, the intradermai injec- 
tion  of  the  type-specific  capsular  polysaccharide  incites  a  response 
characteristic  for  the  species.  The  reaction  to  the  intradermai 
injection  of  the  capsular  polysaccharides  of  Pneumococcus may be 
termed, therefore, a hypersensitive or anaphylactic response occurring 
only in the presence of type-specific immunity. 
SUMMARY 
The injection of the type-specific capsular polysaccharides of Pneu- 
mococcus Types  I,  II  and  III  into  the  skin  of rabbits,  actively  or 
passively immunized to  one of these types of Pneumococcus, elicits 
a  type-specific cutaneous reaction.  The form of reaction  resembles 
that described by Arthus.  The reaction is produced only when type- 
specific precipitins for the homologous polysaccharide are demonstra- 
ble in the Mood of the rabbit.  In 84 per cent of actively immunized 
rabbits,  the  serum  of  which  contained  type-specific  precipitins,  a 
reaction was elicited.  A  positive result was obtained in 100 per cent 
of rabbits passively immunized with antipneumococcus horse serum 
whereas, attempts passively to transfer reactivity from immune rabbit 
to  normal  rabbit  were  unsuccessful.  The  recipients,  in  the  latter 
group, possessed no demonstrable circulating type-specific precipitins. 
The reaction produced by specific capsular  carbohydrates  is always 
associated with a well grounded type-specific immunity. 
A brief summary of the relation of hypersensitiveness and immunity 
to pneumococcus is given. 
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